CoChat
Sign Up
Cited by 1,209Acute Myocardial Infarction ResearchCoronary Interventions and DiagnosticsMechanical Circulatory Support Devices

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock

Open access
Thiele, Holger, Akin, Ibrahim, Sandri, Marcus, Fuernau, Georg, de Waha, Suzanne, Meyer-Saraei, Roza, Nordbeck, Peter, Geisler, Tobias, Landmesser, Ulf, Skurk, Carsten, Fach, Andreas, Lapp, Harald, Piek, Jan J., Noc, Marko, Goslar, Tomaž, Felix, Stephan B., Maier, Lars S., Stepinska, Janina, Oldroyd, Keith, Serpytis, Pranas, Montalescot, Gilles, Barthelemy, Olivier, Huber, Kurt, Windecker, Stephan, Savonitto, Stefano, Torremante, Patrizia, Vrints, Christiaan, Schneider, Steffen, Desch, Steffen, Zeymer, Uwe·2017·New England Journal of Medicine
DOI 10.1056/nejmoa1710261
Open this paper in CoChat — free accountOpen PDF

Abstract

BACKGROUND: In patients who have acute myocardial infarction with cardiogenic shock, early revascularization of the culprit artery by means of percutaneous coronary intervention (PCI) improves outcomes. However, the majority of patients with cardiogenic shock have multivessel disease, and whether PCI should be performed immediately for stenoses in nonculprit arteries is controversial. METHODS: In this multicenter trial, we randomly assigned 706 patients who had multivessel disease, acute myocardial infarction, and cardiogenic shock to one of two initial revascularization strategies: either PCI of the culprit lesion only, with the option of staged revascularization of nonculprit lesions, or immediate multivessel PCI. The primary end point was a composite of death or severe renal failure leading to renal-replacement therapy within 30 days after randomization. Safety end points included bleeding and stroke. RESULTS: At 30 days, the composite primary end point of death or renal-replacement therapy had occurred in 158 of the 344 patients (45.9%) in the culprit-lesion-only PCI group and in 189 of the 341 patients (55.4%) in the multivessel PCI group (relative risk, 0.83; 95% confidence interval [CI], 0.71 to 0.96; P=0.01). The relative risk of death in the culprit-lesion-only PCI group as compared with the multivessel PCI group was 0.84 (95% CI, 0.72 to 0.98; P=0.03), and the relative risk of renal-replacement therapy was 0.71 (95% CI, 0.49 to 1.03; P=0.07). The time to hemodynamic stabilization, the risk of catecholamine therapy and the duration of such therapy, the levels of troponin T and creatine kinase, and the rates of bleeding and stroke did not differ significantly between the two groups. CONCLUSIONS: Among patients who had multivessel coronary artery disease and acute myocardial infarction with cardiogenic shock, the 30-day risk of a composite of death or severe renal failure leading to renal-replacement therapy was lower among those who initially underwent PCI of the culprit lesion only than among those who underwent immediate multivessel PCI. (Funded by the European Union 7th Framework Program and others; CULPRIT-SHOCK ClinicalTrials.gov number, NCT01927549 .).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1710261

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Research works printed but not linked: 2

  1. de Waha S, Eur Heart J Acute Cardiovasc Care
  2. Ibanez B, Eur Heart J

Cited by

Sorted by citations

Items 901–1,000 of 1,000

Related

See all

Metadata

Authors
Thiele, H., Akin, I., Sandri, M., Fuernau, G., de Waha, S., Meyer-Saraei, R., Nordbeck, P., Geisler, T., Landmesser, U., Skurk, C., Fach, A., Lapp, H., Piek, J. J., Noc, M., Goslar, T., Felix, S. B., Maier, L. S., Stepinska, J., Oldroyd, K., Serpytis, P., Montalescot, G., Barthelemy, O., Huber, K., Windecker, S., Savonitto, S., Torremante, P., Vrints, C., Schneider, S., Desch, S., & Zeymer, U.
Affiliations
  • University Hospital Leipzig (DE)
  • Universitätsklinikum Tübingen (DE)
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Ljubljana University Medical Centre (SI)
  • Universität Greifswald (DE)
  • University Hospital Regensburg (DE)
  • Sorbonne Université (FR)
  • Sigmund Freud Privatuniversität Wien (AT)
  • University of Bern (CH)
  • Alessandro Manzoni Hospital (IT)
  • Antwerp University Hospital (BE)
  • Stiftung Institut für Herzinfarktforschung (DE)
ORCID
Venue
New England Journal of Medicine
Publisher
Massachusetts Medical Society
Published
2017-12-21
Volume
377
Issue
25
Pages
2419-2432
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
DOI
10.1056/nejmoa1710261
OpenAlex
W2766152280
Cited by
1,209
References
21
Citations by year
2026: 99 · 2025: 152 · 2024: 175 · 2023: 141 · 2022: 125 · 2021: 138 · 2020: 136 · 2019: 113 · 2018: 111 · 2017: 14
FWCI
78.58
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • HAL (submittedVersion)
  • BORIS (University Library Bern) (submittedVersion, other-oa)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • University of Regensburg Publication Server (University of Regensburg) (submittedVersion)
  • GRO (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion, other-oa)
  • Utrecht University Repository (Utrecht University) (submittedVersion)
  • Open Access CRIS of the University of Bern
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Mechanical Circulatory Support Devices
Keywords
acute myocardial infarction, cardiogenic shock, percutaneous coronary intervention, multivessel coronary artery disease, staged revascularization, early revascularization, renal replacement therapy, mortality, bleeding complications, stroke, hemodynamic stabilization, catecholamine therapy, troponin T, creatine kinase, 30-day outcomes
MeSH terms
Aged, Coronary Artery Disease, Female, Humans, Male, Middle Aged, Myocardial Infarction, Risk, Shock, Cardiogenic, Renal Replacement Therapy, Renal Insufficiency, Kaplan-Meier Estimate, Time-to-Treatment, Percutaneous Coronary Intervention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review